Stock Market Today, March: CytomX Surges on Positive Data
CytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
After an IRA rollover, selecting the right index fund matters for long-term growth and risk management. Compare options and choose confidently.
26,327 articlesCytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
MemeCore completed its second-stage upgrade, slashing gas fees and enabling smoother on-chain activity. The move spar...
Disney is testing a bold move: a unified app that ties together its streaming, parks, and products. This article brea...
A growing number of retirement planners say the common wait until retire tax bet is not broadly effective. Experts ur...
Sen. Elizabeth Warren is demanding answers from Bilt Rewards after reports that rent and mortgage payments were disru...
A sudden 15% drop in Broadcom rattled AI-focused investors. This article breaks down the drivers, explains what it me...
Federal authorities executed a search warrant at a Southern California aerospace site after a chemical tank overheate...
A high-stakes moment for semiconductor supply and AI chip strategy has investors watching ASML. This analysis explain...
The case centers on retired firefighter with $810,000 in savings who discovers Medicare IRMAA surcharges after a lump...
The first half of the year brought a sharp move for ServiceNow as AI expectations collided with reality. This article...
AI-driven demand and memory shortages could propel Micron to new highs by late 2027. This article lays out why a big ...
Delta and United just reported, but the big question remains: what's next airline stocks? This guide breaks down the ...